Correlation Between Pharvaris and XTL Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Pharvaris and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on Pharvaris and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and XTL Biopharmaceutica.
Diversification Opportunities for Pharvaris and XTL Biopharmaceutica
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pharvaris and XTL is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Pharvaris i.e., Pharvaris and XTL Biopharmaceutica go up and down completely randomly.
Pair Corralation between Pharvaris and XTL Biopharmaceutica
Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.91 times more return on investment than XTL Biopharmaceutica. However, Pharvaris BV is 1.1 times less risky than XTL Biopharmaceutica. It trades about -0.08 of its potential returns per unit of risk. XTL Biopharmaceuticals Ltd is currently generating about -0.18 per unit of risk. If you would invest 2,415 in Pharvaris BV on September 2, 2024 and sell it today you would lose (225.00) from holding Pharvaris BV or give up 9.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharvaris BV vs. XTL Biopharmaceuticals Ltd
Performance |
| Timeline |
| Pharvaris BV |
| XTL Biopharmaceuticals |
Pharvaris and XTL Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and XTL Biopharmaceutica
The main advantage of trading using opposite Pharvaris and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
| XTL Biopharmaceutica vs. Tff Pharmaceuticals | XTL Biopharmaceutica vs. Eliem Therapeutics | XTL Biopharmaceutica vs. Inhibrx | XTL Biopharmaceutica vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |